Gilead Sciences has been overwhelmed with requests for remdesivir to treat cases of COVID-19, the disease caused by the novel coronavirus.

A lot of attention shifted to the malaria drug hydroxychloroquine for treatment of COVID-19, the disease caused by the novel coronavirus.

U.S. drugmaker Bristol Myers Squibb Co. will put off beginning new clinical trials for at least three weeks because of the impact of the fast-spreading coronavirus pandemic.

Scientists at Britain’s Oxford University started a clinical trial to investigate the effects of an HIV medicine and a steroid drug in UK patients admitted to hospital with COVID-19 caused by the new coronavirus.

The U.S. Food and Drug Administration approved the first rapid coronavirus diagnostic test – with a detection time of about 45 minutes – said the test’s developer, California-based molecular diagnostics company Cepheid.

MultiStem, a cell therapy in development at Athersys, was recently designated “Highly Relevant” as a Potential Therapy for COVID-19 by BARDA. This is the only therapy in development that targets acute respiratory distress syndrome (ARDS), the pneumonia-like condition that leads to severe illness and death among COVID-19 patients, and is the only one ARDS therapy that has also received Fast Track designation from the FDA.

BioSpace reviews some of the more interesting scientific studies recently published, including an unusual molecular chaperone implicated in Alzheimer’s disease.

Shares of FujiFilm spiked more than 26 percent after reports that the company’s flu drug favipiravir proved effective in treating coronavirus cases in China.

Days after Roche began shipping hundreds of thousands of the Swiss pharma giant’s recently approved COVID-19 test to laboratories in the United States, the company initiated a late-stage trial assessing the rheumatoid arthritis drug Actemra in patients who have severe COVID-19 caused pneumonia.

Pfizer announced positive results from two Phase III trials, one in moderate-to-severe atopic dermatitis and another in pneumococcal disease.